Hepatic glucose production (HGP) is crucial for blood glucose homeostasis, while an impaired regulation of HGP contributes to hyperglycemia in patients with type 2 diabetes mellitus. Hepatokines are proteins secreted by hepatocytes, and some of them can directly affect glucose metabolism. Here we examined the role of transforming growth factor beta 1 (TGF-β1) in regulating glucose homeostasis. We generated the liver-specific TGF-beta1 knockout mice and found that hepatic TGF-β1 deficient mice exhibited a lower blood glucose levels. Hepatic TGF-β1 deficiency increased insulin sensitivity and protected mice from diet-induced obesity and hyperglycemia. In vitro studies using mouse primary hepatocytes, TGF-β1 augmented glycogenolysis and gluconeogenesis, activated protein kinase A (PKA) signaling, promoted the stability of the O-class of the forkhead transcription factor 1 (Foxo1), and increased the level of key gluconeogenic genes, glucose-6-phosphatase (G6Pase) and phosphorenolpyruvate carboxykinase (PEPCK). These findings underscore an important role of hepatic TGF-β1 in contribution to blood glucose homeostasis, and hepatic TGF-β1 may serve as an important hepatokine and therapeutic target for glycemic control in insulin resistance and type 2 diabetes mellitus.

Disclosure

Q. Pan: None. Y. Chen: None. H. Yan: None. W. Yang: None. Z. Shen: None. S.A. Dahanayaka: None. S. Guo: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.